Compare Enzyme (MLN) vs UMA (UMA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enzyme vs UMA — how do they compare? Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume), while UMA trades at Rp5,782 (market cap Rp523,62M, Rp28,23M 24h volume). The key difference: UMA is far larger — about 3.9× Enzyme's market cap, and Enzyme's circulating supply is 3,3M MLN versus 90,6M UMA for UMA. Which is the better fit depends on your goals — on Pluang, investors hold Enzyme for 29 Days and UMA for 72 Days on average.
| MLN | UMA | |
|---|---|---|
Market Cap | Rp134,13M | Rp523,62M |
Volume (24h) | Rp104,56M | Rp28,23M |
Circulating Supply | 3,3M MLN | 90,6M UMA |
Typical Hold Time | 29 Days | 72 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Enzyme (MLN) shows limited market activity with a modest market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates relatively low volatility with an average hold time of 29 days, suggesting stable holder behavior. Trading volumes appear subdued across exchanges, indicating limited speculative interest. No significant protocol upgrades or ecosystem developments have been reported recently, though the project continues to operate its decentralized asset management platform.
Overall outlook remains cautious due to limited liquidity and trading activity. Key opportunities include potential ecosystem growth in decentralized finance asset management, while major risks include low market depth, regulatory uncertainty for DeFi protocols, and competition from larger DeFi platforms. The token's utility within its native protocol remains its primary value driver.
UMA is currently trading at Rp5,782 with a market cap of Rp523.62 million, showing bearish technical signals overall despite bullish oscillators. The token faces consolidation with all support and resistance levels converging at the current price. Hold time of 72 days suggests moderate investor patience. No major protocol updates or ecosystem developments have been reported recently.
Overall outlook remains cautious with oversold RSI indicators suggesting potential short-term bounce opportunities. Major risks include low liquidity, high volatility, and regulatory uncertainty. Investors should monitor for any upcoming protocol upgrades or exchange listings that could impact price action.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →About UMA
UMA, or Universal Market Access, is a protocol for the creation of synthetic assets based on the Ethereum (ETH) blockchain. UMA allows counterparties to digitize and automate any real-world financial derivatives, such as futures, contracts for differences (CFDs) or total return swaps.
Read more on UMA →
